WZ811

CAS No. 55778-02-4

WZ811( WZ811 | WZ-811 | WZ 811 )

Catalog No. M15027 CAS No. 55778-02-4

WZ811 is a novel small molecular and potency CXCR4 antagonist with EC50 of 0.3 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 43 In Stock
10MG 55 In Stock
25MG 104 In Stock
50MG 167 In Stock
100MG 233 In Stock
200MG 302 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    WZ811
  • Note
    Research use only, not for human use.
  • Brief Description
    WZ811 is a novel small molecular and potency CXCR4 antagonist with EC50 of 0.3 nM.
  • Description
    WZ811 is a novel small molecular and potency CXCR4 antagonist with EC50 of 0.3 nM.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    WZ811 | WZ-811 | WZ 811
  • Pathway
    Autophagy
  • Target
    CXCR
  • Recptor
    CXCR4
  • Research Area
    Inflammation/Immunology
  • Indication
    ——

Chemical Information

  • CAS Number
    55778-02-4
  • Formula Weight
    290.36
  • Molecular Formula
    C18H18N4
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 30 mg/mL (103.32 mM)
  • SMILES
    C1(CNC2=NC=CC=C2)=CC=C(CNC3=NC=CC=C3)C=C1
  • Chemical Name
    N,N'-(1,4-phenylenebis(methylene))bis(pyridin-2-amine)

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Zhan W, et al. J Med Chem, 2007, 50(23), 5655-5664.
molnova catalog
related products
  • Delmetacin

    Delmetacin (Demethacin) is a non-steroidal anti-inflammatory compound with anti-inflammatory and analgesic activity and inhibitory effects on the CXC chemokine receptor CXCR1.

  • NUCC-390

    NUCC-390, a novel small-molecule CXCR4 receptor agonist, selectively induces CXCR4 receptor internalization while acting antagonistically to AMD3100.

  • AMD 3465 hexahydrobr...

    AMD 3465 hexahydrobromide is a CXCR4 receptor antagonist with potential anticancer and anti-HIV activity.